- War against Diabetes and Obesity
War against Diabetes and Obesity
The prevalence of diabetes has doubled in the past decade, and the resulting increases in diabetes-related eye disease pose a new challenge to eye specialists, according to an editorial in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Two editorials and a research article in the issue focus on ophthalmologic implications of metabolic diseases, and are being published in conjunction with a JAMA theme issue on diabetes, obesity and their comorbidities. The March issue of Archives of Neurology, along with the April issues of Archives of Pediatrics & Adolescent Medicine, Archives of Dermatology and Archives of Surgery, will also focus on this theme.
“By 2050, the number of Americans with diabetic retinopathy [affecting blood vessels in the retina] is projected to triple from 5.5 million to 16 million, and the number of those with vision-threatening retinopathy will increase from 1.2 million to 3.4 million,” write Thomas W. Gardner, M.D., M.S., and Robert A. Gabbay, M.D., Ph.D., of Penn State College of Medicine, Hershey, Pa., in the first editorial. “The number of cataracts will increase by 235 percent and glaucoma among elderly Hispanic individuals with diabetes will increase 12-fold.”
To effectively treat these conditions, ophthalmologists must go beyond surgically treating late-stage eye disease and work with other clinicians to help patients control their diabetes before eye complications worsen, Dr. Gardner and Dr. Gabbay note. “Ophthalmologists have a unique opportunity to influence patient behavior because vision loss is one of the most feared complications of diabetes. Helping patients make the connection between their eye disease and the ABCs of diabetes (A1C, blood pressure and cholesterol) can motivate them to improve their health.”
Arch Ophthalmol. 2009;127:328-329
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2018, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.